Sonderborg Hospital
Sønderborg, Southern Denmark, 6400, Denmark
NCT Number: NCT04059211
Urinary dipsticks are commonly used in emergency departments since they are a cheap and quick diagnostic tool. However the sensitivity and specificity of urinary dipsticks might be compromised in emergency departments due to fluid imbalance and acute illness itself.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Sønderborg, Southern Denmark, 6400, Denmark
The study is designed as a prospective observational study on the emergency department in Sonderborg, Southern Denmark.
All patients above 18 years of age who have given their consent are included. Urinary dipstick and albumin creatinine ratio is obtained simultaneously within 48 hours after admission on the emergency department.
Patient with a positive urinary dipstick will be asked to deliver another urinary dipstick and albumin creatinine ratio 3-8 weeks later.
To our knowledge has the specificity and sensitivity of urinary dipstick for protein not been described, yet. Our design will give us the possibility not only to quantify specificity and sensitivity in the acute phase on the emergency department but in the non-acute phase after discharge from the emergency department, as well.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sensitivity and specificity of urinary dipstick for proteinuria in emergency departments
Time frame: 5 months
Sonderborg Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07260292
Chronic Disease, Chronic Kidney Disease Stage 3
Taichung, Taiwan
View Trial DetailsNCT07150338
Chronic Disease, Chronic Kidney Disease (Stage 3-4)
Pasadena, Texas, United States
View Trial DetailsNCT00817037
Blood Pressure, Chronic Disease
Edinburgh, Scotland, United Kingdom
View Trial DetailsNCT05759754
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hefei, Anhui, China
View Trial Details